Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis
- DOI
- 10.3389/falgy.2026.1766647
- Published
- 2026-03-06
- Container
- Frontiers in Allergy
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/falgy.2026.1766647,
title = {Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis},
author = {Enrico Heffler and Diana Jarreta and Chang-Qing Zhu and Anna Vichiendilokkul and Peter Howarth and Anju Peters and Santiago Quirce and David J. Jackson},
year = {2026},
journal = {Frontiers in Allergy},
doi = {10.3389/falgy.2026.1766647},
url = {https://doi.org/10.3389/falgy.2026.1766647}
}RIS
TY - JOUR TI - Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis AU - Enrico Heffler AU - Diana Jarreta AU - Chang-Qing Zhu AU - Anna Vichiendilokkul AU - Peter Howarth AU - Anju Peters AU - Santiago Quirce AU - David J. Jackson PY - 2026 JO - Frontiers in Allergy DO - 10.3389/falgy.2026.1766647 UR - https://doi.org/10.3389/falgy.2026.1766647 ER -
APA
Heffler, E., Jarreta, D., Zhu, C., Vichiendilokkul, A., Howarth, P., Peters, A., Quirce, S., & Jackson, D. J. (2026). Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis. Frontiers in Allergy. https://doi.org/10.3389/falgy.2026.1766647
Source records
- crossref · retrieved 2026-09-26T10:15:33.804Z